Clinical Trials in Houston

Showing 9481-9500 of 13,620 trials

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

NCT00003176

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of temozolomide and carmustine in treating patients with anaplastic glioma.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins82 participantsStarted Mar 1998

Los Angeles, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States +7 more locations

COMPLETEDPhase 4< 1 mile

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

NCT00078338

The primary objective of the study is to assess the clinical efficacy of Rebif® 44 microgram (mcg) three times per week compared with Copaxone® 20 milligram (mg) daily in subjects with relapsing Multiple Sclerosis.

Relapsing-remitting Multiple Sclerosis

EMD Serono764 participantsStarted Feb 2004

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +77 more locations

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Find Trials by Condition in Houston

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Vistakon Investigational Multi-purpose Contact Lens Care Solution.

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens

Acute Study to Collect Electrical Signals From the Heart Using a Special Lead

Dispensing Evaluation of Printed Etafilcon A With Polyvinylpyrrolidone (PVP)